Cooper-Standard Holdings Inc., operating primarily through its subsidiary Cooper-Standard Automotive Inc., is an enterprise dedicated to the engineering, production, and sale of vital automotive components, specifically sealing, fuel and braking, and fluid conveyance systems. Its comprehensive portfolio of sealing solutions encompasses obstacle detection sensor setups, adaptable dynamic and static seals, innovative variable extrusion systems, specialized sealing items, encapsulated glass components, stainless steel trim elements, FlushSeal technologies, and aesthetically textured surfaces mimicking fabric. For fuel and braking distribution, the company offers chassis and tank fuel lines (including bundled options), direct injection and port fuel rails, metallic brake lines (also offered in bundles), protective tube coatings, convenient quick connection mechanisms, advanced low oligomer multi-layer convoluted tubes, and brake jounce lines. Furthermore, its fluid transfer systems include heater and coolant hoses, turbocharger hoses, quick connect fittings, charged air cooler ducts and assemblies, DPF and SCR emission lines, secondary air hoses, degas tanks, hoses for brakes and clutches, air intake and charge systems, transmission oil cooling hoses, and specialized multilayer tubing for glycol-based thermal regulation. These components are predominantly integrated into passenger vehicles and light trucks, serving both original equipment manufacturers (OEMs) and the aftermarket for replacement parts. Cooper-Standard maintains a broad international footprint, with operations in countries such as the United States, Mexico, China, Poland, Canada, Germany, and France, among other global locations. The company was founded in 1960 and has its principal corporate office in Northville, Michigan.
gurufocus.comThe Empty Nest Is on Hold: 1 in 3 Adults Under 35 Lives With Their Parents, Realtor.com® Findsgurufocus.comJun 18
prnewswire.comCooper Standard Recognized as a Finalist for IndustryWeek's Best Plants Awardsprnewswire.comJun 16
gurufocus.comFDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lunggurufocus.comMay 29
prnewswire.comCooper Standard Named a 2025 Supplier of the Year by General Motorsprnewswire.comMay 28
prnewswire.comCooper Standard Highlights Resilience, Performance and Sustainability Progress in 2025 Corporate Responsibility Reportprnewswire.comMay 13